Literature DB >> 2456948

Omega-conotoxin binding and effects on calcium channel function in human neuroblastoma and rat pheochromocytoma cell lines.

E Sher1, A Pandiella, F Clementi.   

Abstract

Binding of omega-conotoxin, a peptide toxin specific for some subtypes of voltage-operated calcium channels (VOCCs), was investigated in IMR32 neuroblastoma and PC12 pheochromocytoma cell lines. In both cell types, binding was specific, saturable and of high affinity. Association was rapid and dissociation almost non-existent. Dihydropyridines and verapamil failed to affect toxin binding, while high concentrations of CaCl2 completely antagonized it. Depolarization with high K+ induced a [Ca2+]i rise (revealed by the fura-2 fluorimetric technique) that consisted of an initial (0.5-1 min) peak followed by a prolonged (several minutes) plateau phase. omega-Conotoxin blocked mainly the first phase, while the dihydropyridine Ca2+ channel blocker, nitrendipine, primarily affected the plateau. This result suggests that in the two cell lines investigated, omega-conotoxin acts mainly on a subgroup of VOCCs that is resistant to dihydropyridines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456948     DOI: 10.1016/0014-5793(88)81258-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.

Authors:  C Leveque; T Hoshino; P David; Y Shoji-Kasai; K Leys; A Omori; B Lang; O el Far; K Sato; N Martin-Moutot
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 2.  Metabolism and trafficking of N-type voltage-operated calcium channels in neurosecretory cells.

Authors:  E Sher; P Rosa; M Francolini; A Codignola; E Morlacchi; E Taverna; F Giovannini; A Brioschi; F Clementi; M W McEnery; M Passafaro
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

3.  Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells.

Authors:  P J Owen; D B Marriott; M R Boarder
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

4.  Differential expression by nerve growth factor of two types of Ca2+ channels in rat phaeochromocytoma cell lines.

Authors:  M M Usowicz; H Porzig; C Becker; H Reuter
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

5.  Multiple calcium channel subtypes in isolated rat chromaffin cells.

Authors:  L Gandía; R Borges; A Albillos; A G García
Journal:  Pflugers Arch       Date:  1995-05       Impact factor: 3.657

6.  Possible involvement of both N- and L-type voltage-dependent Ca channels in adrenergic neurotransmission of canine saphenous veins in low Ca2+ plus tetraethylammonium medium.

Authors:  Y Takata; J Ozawa; H Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

7.  Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.

Authors:  K O Lövblad; J Boucraut; S Bourdenet; D Burger; D Bernard; F Regli; A J Steck
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

8.  Differential effects of calcium channel antagonists (omega-conotoxin GVIA, nifedipine, verapamil) on the electrically-evoked release of [3H]acetylcholine from the myenteric plexus, phrenic nerve and neocortex of rats.

Authors:  I Wessler; D J Dooley; J Werhand; F Schlemmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

9.  Two types of high-threshold calcium currents inhibited by omega-conotoxin in nerve terminals of rat neurohypophysis.

Authors:  X Wang; S N Treistman; J R Lemos
Journal:  J Physiol       Date:  1992-01       Impact factor: 5.182

10.  Calcium mobilization induced by endothelins and sarafotoxin in cultured canine tracheal smooth muscle cells.

Authors:  C M Yang; Y L Yo; R Ong; J T Hsieh; H L Tsao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.